Healthcare Industry Reports

Reports > Healthcare > Selected Report

Global Onychomycosis (Tinea Unguium) Drug Market Report for Period 2018 till 2024

Single User: $2195
Multiple User: $3195
Enterprise User: $4195


Report Summary:

Onychomycosis is a fungal infection of the toenails or fingernails that may involve any component of the nail unit, including the matrix, bed, or plate.
Onychomycosis (Tinea Unguium) Drug is the drug for the treatment of the disease

Scope of the Report:
This report focuses on the Onychomycosis (Tinea Unguium) Drug in global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, types and applications.
Market Segment by Manufacturers, this report covers
Johnson & Johnson
GSK
Novartis
Pfizer
Valeant Pharma
Kaken Pharmaceutical
Galderma
Xiuzheng Pharmaceutical
Letai
Qilu Pharmaceutical

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Oral
External

Market Segment by Applications, can be divided into
Age under 18
Age 18-50
Age above 50

There are 15 Chapters to deeply display the global Onychomycosis (Tinea Unguium) Drug market.

Chapter 1, to describe Onychomycosis (Tinea Unguium) Drug Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Onychomycosis (Tinea Unguium) Drug , with sales, revenue, and price of Onychomycosis (Tinea Unguium) Drug , in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Onychomycosis (Tinea Unguium) Drug , for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the key regions, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Onychomycosis (Tinea Unguium) Drug market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Onychomycosis (Tinea Unguium) Drug sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Table of Contents / Index:

Table of Contents
1 Market Overview
1.1 Onychomycosis (Tinea Unguium) Drug Introduction
1.2 Market Analysis by Type
1.2.1 Oral
1.2.2 External
1.3 Market Analysis by Applications
1.3.1 Age under 18
1.3.2 Age 18-50
1.3.3 Age above 50
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market Status and Outlook (2013-2023)
1.4.1.2 Canada Market Status and Outlook (2013-2023)
1.4.1.3 Mexico Market Status and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market Status and Outlook (2013-2023)
1.4.2.2 France Market Status and Outlook (2013-2023)
1.4.2.3 UK Market Status and Outlook (2013-2023)
1.4.2.4 Russia Market Status and Outlook (2013-2023)
1.4.2.5 Italy Market Status and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market Status and Outlook (2013-2023)
1.4.3.2 Japan Market Status and Outlook (2013-2023)
1.4.3.3 Korea Market Status and Outlook (2013-2023)
1.4.3.4 India Market Status and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market Status and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market Status and Outlook (2013-2023)
1.4.4.2 Egypt Market Status and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market Status and Outlook (2013-2023)
1.4.4.4 South Africa Market Status and Outlook (2013-2023)
1.4.4.5 Nigeria Market Status and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Johnson & Johnson
2.1.1 Business Overview
2.1.2 Onychomycosis (Tinea Unguium) Drug Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Johnson & Johnson Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 GSK
2.2.1 Business Overview
2.2.2 Onychomycosis (Tinea Unguium) Drug Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 GSK Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Novartis
2.3.1 Business Overview
2.3.2 Onychomycosis (Tinea Unguium) Drug Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 Novartis Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Pfizer
2.4.1 Business Overview
2.4.2 Onychomycosis (Tinea Unguium) Drug Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 Pfizer Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Valeant Pharma
2.5.1 Business Overview
2.5.2 Onychomycosis (Tinea Unguium) Drug Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 Valeant Pharma Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Kaken Pharmaceutical
2.6.1 Business Overview
2.6.2 Onychomycosis (Tinea Unguium) Drug Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.3 Kaken Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Galderma
2.7.1 Business Overview
2.7.2 Onychomycosis (Tinea Unguium) Drug Type and Applications
2.7.2.1 Type 1
2.7.2.2 Type 2
2.7.3 Galderma Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Xiuzheng Pharmaceutical
2.8.1 Business Overview
2.8.2 Onychomycosis (Tinea Unguium) Drug Type and Applications
2.8.2.1 Type 1
2.8.2.2 Type 2
2.8.3 Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Letai
2.9.1 Business Overview
2.9.2 Onychomycosis (Tinea Unguium) Drug Type and Applications
2.9.2.1 Type 1
2.9.2.2 Type 2
2.9.3 Letai Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Qilu Pharmaceutical
2.10.1 Business Overview
2.10.2 Onychomycosis (Tinea Unguium) Drug Type and Applications
2.10.2.1 Type 1
2.10.2.2 Type 2
2.10.3 Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Onychomycosis (Tinea Unguium) Drug Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Onychomycosis (Tinea Unguium) Drug Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Onychomycosis (Tinea Unguium) Drug Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Onychomycosis (Tinea Unguium) Drug Manufacturer Market Share
3.3.2 Top 6 Onychomycosis (Tinea Unguium) Drug Manufacturer Market Share
3.4 Market Competition Trend
4 Global Onychomycosis (Tinea Unguium) Drug Market Analysis by Regions
4.1 Global Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Onychomycosis (Tinea Unguium) Drug Sales and Market Share by Regions (2013-2018)
4.1.2 Global Onychomycosis (Tinea Unguium) Drug Revenue and Market Share by Regions (2013-2018)
4.2 North America Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2013-2018)
4.3 Europe Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2013-2018)
4.5 South America Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2013-2018)
5 North America Onychomycosis (Tinea Unguium) Drug by Countries
5.1 North America Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Market Share by Countries
5.1.1 North America Onychomycosis (Tinea Unguium) Drug Sales and Market Share by Countries (2013-2018)
5.1.2 North America Onychomycosis (Tinea Unguium) Drug Revenue and Market Share by Countries (2013-2018)
5.2 United States Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2013-2018)
5.3 Canada Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2013-2018)
5.4 Mexico Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2013-2018)
6 Europe Onychomycosis (Tinea Unguium) Drug by Countries
6.1 Europe Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Market Share by Countries
6.1.1 Europe Onychomycosis (Tinea Unguium) Drug Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Onychomycosis (Tinea Unguium) Drug Revenue and Market Share by Countries (2013-2018)
6.2 Germany Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2013-2018)
6.3 UK Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2013-2018)
6.4 France Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2013-2018)
6.5 Russia Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2013-2018)
6.6 Italy Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2013-2018)
7 Asia-Pacific Onychomycosis (Tinea Unguium) Drug by Countries
7.1 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Revenue and Market Share by Countries (2013-2018)
7.2 China Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2013-2018)
7.3 Japan Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2013-2018)
7.4 Korea Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2013-2018)
7.5 India Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2013-2018)
8 South America Onychomycosis (Tinea Unguium) Drug by Countries
8.1 South America Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Market Share by Countries
8.1.1 South America Onychomycosis (Tinea Unguium) Drug Sales and Market Share by Countries (2013-2018)
8.1.2 South America Onychomycosis (Tinea Unguium) Drug Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2013-2018)
8.3 Argentina Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2013-2018)
8.4 Colombia Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2013-2018)
9 Middle East and Africa Onychomycosis (Tinea Unguium) Drug by Countries
9.1 Middle East and Africa Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Onychomycosis (Tinea Unguium) Drug Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Onychomycosis (Tinea Unguium) Drug Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2013-2018)
9.3 UAE Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2013-2018)
9.4 Egypt Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2013-2018)
9.5 Nigeria Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2013-2018)
9.6 South Africa Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate (2013-2018)
10 Global Onychomycosis (Tinea Unguium) Drug Market Segment by Type
10.1 Global Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Onychomycosis (Tinea Unguium) Drug Sales and Market Share by Type (2013-2018)
10.1.2 Global Onychomycosis (Tinea Unguium) Drug Revenue and Market Share by Type (2013-2018)
10.2 Oral Sales Growth and Price
10.2.1 Global Oral Sales Growth (2013-2018)
10.2.2 Global Oral Price (2013-2018)
10.3 External Sales Growth and Price
10.3.1 Global External Sales Growth (2013-2018)
10.3.2 Global External Price (2013-2018)
11 Global Onychomycosis (Tinea Unguium) Drug Market Segment by Application
11.1 Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application (2013-2018)
11.2 Age under 18 Sales Growth (2013-2018)
11.3 Age 18-50 Sales Growth (2013-2018)
11.4 Age above 50 Sales Growth (2013-2018)
12 Onychomycosis (Tinea Unguium) Drug Market Forecast (2018-2023)
12.1 Global Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Growth Rate (2018-2023)
12.2 Onychomycosis (Tinea Unguium) Drug Market Forecast by Regions (2018-2023)
12.2.1 North America Onychomycosis (Tinea Unguium) Drug Market Forecast (2018-2023)
12.2.2 Europe Onychomycosis (Tinea Unguium) Drug Market Forecast (2018-2023)
12.2.3 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Market Forecast (2018-2023)
12.2.4 South America Onychomycosis (Tinea Unguium) Drug Market Forecast (2018-2023)
12.2.5 Middle East and Africa Onychomycosis (Tinea Unguium) Drug Market Forecast (2018-2023)
12.3 Onychomycosis (Tinea Unguium) Drug Market Forecast by Type (2018-2023)
12.3.1 Global Onychomycosis (Tinea Unguium) Drug Sales Forecast by Type (2018-2023)
12.3.2 Global Onychomycosis (Tinea Unguium) Drug Market Share Forecast by Type (2018-2023)
12.4 Onychomycosis (Tinea Unguium) Drug Market Forecast by Application (2018-2023)
12.4.1 Global Onychomycosis (Tinea Unguium) Drug Sales Forecast by Application (2018-2023)
12.4.2 Global Onychomycosis (Tinea Unguium) Drug Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

Research Methodology

The market research report added recently to collection of Market Reports Company is based on detailed qualitative and quantitative analysis. The research report is a blend of both bottom up and top down research with the help of which quantitative aspects of the market are determined. Besides this various statistical models, projection techniques and sampling techniques are implemented for quantitative analysis.
The qualitative analysis includes through interactive study with all major industry participants across the industrial value chain. The analysis includes extensive interviews with raw material suppliers, experienced front line staff, directors, CEOs, distributors, major manufacturers, industry experts and end-users. Interaction are usually done with the help of primary interviews, surveys, and vendor briefings. All major factors that influence this market are studied in this research report. The market size for top level markets and sub-segments is normalized, and the impact of various macro and micro economic factors are analyzed during market forecast.

Secondary Research
Secondary sources play a vital role in collection of raw data. Various paid and open access data sources are referred for collection for secondary data. Some of the major secondary data sources referred include:

■ Press releases, annual reports, Non-Profit organizations
■ Industry associations, governmental agencies and customs data
■ Directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), etc.

Primary Research
In Primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Some of the major primary sources include:

■ Product manufacturers
■ Opinion leaders, industry experts and research institutions
■ Distributors, Dealer and Traders
■ Raw Materials suppliers and producers etc.

The data collected through secondary research is validated with the help of primary research respondents.

Data Models
Wherever no credible data sources are available, various data models are implemented which help to develop wide data sets.

Request a Sample of this Report

Please fill out the details requested below.
Our representative will contact you within 1 hour.


Name:


Email ID:


Name of Company:


Designation/Role:


Country:


Message:


Please Enter Captcha Below:

Report Details:



Report ID: 38145

Category: 11

Published date: 2018-03-25 14:19:32

Number of Pages: 100

Publisher Name: GIR

Over all Rating: 80 % (Average of Ratings provided by clients)